Shoulder Innovations’ (SI) “Overweight” Rating Reaffirmed at Piper Sandler

Posted by George Bondi on Aug 7th, 2026

Shoulder Innovations (NYSE:SI – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts at Piper Sandler in a research report issued on Friday,Benzinga reports. They presently have a $25.00 target price on the stock, up from their prior target price of $19.00. Piper Sandler’s price objective would suggest a potential upside of 26.14% from the company’s current price.

A number of other brokerages also recently issued reports on SI. UBS Group initiated coverage on shares of Shoulder Innovations in a research note on Tuesday, July 28th. They set a “buy” rating and a $27.00 price objective on the stock. BTIG Research boosted their price target on Shoulder Innovations from $24.00 to $26.00 and gave the stock a “buy” rating in a report on Friday. Finally, Weiss Ratings raised Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday. Six investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $23.33.

Read Our Latest Stock Analysis on SI

Shoulder Innovations Stock Performance

Shares of NYSE SI traded down $2.61 during trading hours on Friday, reaching $19.82. 130,534 shares of the stock were exchanged, compared to its average volume of 92,414. The company has a debt-to-equity ratio of 0.11, a quick ratio of 10.04 and a current ratio of 11.81. The firm has a market capitalization of $411.07 million and a price-to-earnings ratio of -0.12. The stock’s fifty day simple moving average is $19.79 and its 200 day simple moving average is $16.04. Shoulder Innovations has a 52 week low of $10.92 and a 52 week high of $24.59.

Shoulder Innovations (NYSE:SI – Get Free Report) last posted its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.03. Shoulder Innovations had a negative return on equity of 35.11% and a negative net margin of 81.78%.The company had revenue of $16.71 million during the quarter. Sell-side analysts predict that Shoulder Innovations will post -1.67 EPS for the current year.

Insider Buying and Selling at Shoulder Innovations

In other news, COO Matthew Fraser Ahearn sold 4,144 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $18.84, for a total transaction of $78,072.96. Following the transaction, the chief operating officer directly owned 269,176 shares of the company’s stock, valued at $5,071,275.84. This represents a 1.52% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Healthcare Holding B.V. Gilde sold 99,812 shares of the firm’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $22.77, for a total transaction of $2,272,719.24. Following the completion of the transaction, the insider directly owned 2,221,640 shares in the company, valued at $50,586,742.80. This trade represents a 4.30% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 178,842 shares of company stock valued at $4,006,314. Insiders own 29.00% of the company’s stock.

Institutional Investors Weigh In On Shoulder Innovations

Institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Shoulder Innovations in the 3rd quarter worth $28,000. Rhumbline Advisers bought a new stake in Shoulder Innovations in the 3rd quarter valued at about $54,000. Wells Fargo & Company MN grew its stake in Shoulder Innovations by 66.3% in the 4th quarter. Wells Fargo & Company MN now owns 5,250 shares of the company’s stock valued at $75,000 after buying an additional 2,094 shares in the last quarter. Renaissance Technologies LLC purchased a new stake in shares of Shoulder Innovations in the fourth quarter worth about $176,000. Finally, Blue Trust Inc. purchased a new stake in shares of Shoulder Innovations in the first quarter worth $228,000.

Shoulder Innovations Company Profile

(Get Free Report)

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.